End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: Performance under optimal and suboptimal conditions

Journal of Virological Methods

Volumn 151, Issue 2, 2008, Pages 217-224

  Ramachandran, Sumathi ^a   Xia, Guo liang ^a   Ganova Raeva, Lilia M ^a   Nainan, Omana V ^a   Khudyakov, Yury ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hepatitis C virus; HVR1; Limiting dilution; Molecular epidemiology; PCR; Quasispecies

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; END POINT LIMITING DILUTION; EPIDEMIC; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C VIRUS; HIGH TEMPERATURE; HUMAN; HVR1 GENE; LONGITUDINAL STUDY; MELTING PEAK ANALYSIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PARAMETER; PHYLOGENY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SERUM; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN;

ACUTE DISEASE; DISEASE OUTBREAKS; DNA PRIMERS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; POLYMERASE CHAIN REACTION; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SERUM; UNITED STATES;

HEPATITIS C VIRUS;

EID: 46749091188     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.05.005     Document Type: Article

References (40)

1. Alter M.J. Epidemiology of hepatitis C. Hepatology 26 (1997) 62S-65S
2. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., Kaslow R.A., and Margolis H.S. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341 (1999) 556-562
3. Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., and Alter M.J. The prevalence of hepatitis C virus infection in the United States: 1999 through 2002. Ann. Intern. Med. 144 (2006) 705-714
4. Ayers M., Siu K., Roberts E., Garvin A.M., and Tellier R. Characterization of hepatitis C virus quasispecies by matrix-assisted laser desorption ionization-time of flight (mass spectrometry) mutation detection. J. Clin. Microbiol. 40 (2002) 3455-3462
5. Blaak H. Isolation of human immunodeficiency virus type 2 biological clones from peripheral blood lymphocytes. Methods Mol. Biol. 304 (2005) 95-112
6. Curran R., Jameson C.L., Craggs J.K., Grabowska A.M., Thomson B.J., Robins A., Irving W.L., and Ball J.K. Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. J. Gen. Virol. 83 (2002) 11-23
7. Greenier J.L., Van Rompay K.K., Montefiori D., Earl P., Moss B., and Marthas M.L. Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals. Virol. J. 14 (2005) 2-11
8. Jeffreys A.J., Neumann R., and Wilson V. Repeat unit sequence variation in minisatellites: a novel source of DNA polymorphism for studying variation and mutation by single molecule analysis. Cell 60 (1990) 473-485
9. Jeffreys A.J., Wilson V., Neumann R., and Keyte J. Amplification of human minisatellites by the polymerase chain reaction: towards DNA fingerprinting of single cells. Nucleic Acids Res. 16 (1998) 10953-10971
10. Kono Y., Hayashida K., Tanaka H., Ishibashi H., and Harada M. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. J. Med. Virol. 70 (2003) 42-48
11. Kraytsberg Y., Schwartz M., Brown T.A., Ebralidse K., Kunz W.S., Clayton D.A., Vissing J., and Khrapko K. Recombination of human mitochondrial DNA. Science 304 (2004) 981
12. Kraytsberg Y., and Khrapko K. Single-molecule PCR: an artifact-free PCR approach for the analysis of somatic mutations. Expert Rev. Mol. Diagn. 5 (2005) 809-815
13. Lohmann V., Roos A., Korner F., Koch J.O., and Bartenschlager R. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J. Viral Hepat. 7 (2000) 167-174
14. Lukyanov K.A., Matz M.V., Bogdanova E.A., Gurskaya N.G., and Lukyanov S.A. Molecule by molecule PCR amplification of complex DNA mixtures for direct sequencing: an approach to in vitro cloning. Nucleic Acids Res. 24 (1996) 2194-2195
15. Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
16. Meyerhans A., Vartanian J.P., and Wain-Hobson S. DNA recombination during PCR. Nucleic Acids Res. 18 (1990) 1687-1691
17. Mitra R.D., Butty V.L., Shendure J., Williams B.R., Housman D.E., and Church G.M. Digital genotyping and haplotyping with polymerase colonies. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5926-5931
18. Morishima, C., Polyak, S.J., Ray, R., Doherty, M.C., Di Bisceglie, A.M., Malet, P.F., Bonkovsky, H.L., Sullivan, D.G., Gretch, D.R., Rothman, A.L., Koziel, M.J., Lindsay, K.L., Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group, 2006. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J. Infect. Dis. 193, 931-940.
19. Nainan O.V., Khristova M.L., Byun K., Xia G., Taylor P.E., Stevens C.E., and Margolis H.S. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J. Med. Virol. 68 (2002) 319-327
20. Nainan O.V., Lu L., Gao F.X., Meeks E., Robertson B.H., and Margolis H.S. Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees. J. Gen. Virol. 87 (2006) 83-91
21. Nakano I., Maertens G., Major M.E., Vitvitski L., Dubuisson J., Fournillier A., De Martynoff G., Trepo C., and Inchauspe G. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J. Virol. 71 (1997) 7101-7109
22. Ngui S.L., and Teo C.G. Hepatitis B virus genomic heterogeneity: variation between quasispecies may confound molecular epidemiological analyses of transmission incidents. J. Viral Hepat. 4 (1997) 309-315
23. Okamoto H., Kojima M., Okada S., Yoshizawa H., Iizuka H., Tanaka T., Muchmore E.E., Peterson D.A., Ito Y., and Mishiro S. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190 (1992) 894-899
24. Ramachandran S., Xia G., Nainan O.V., and Khudyakov Y. Temporal patterns of quasispecies in chronic HCV infected patients. Proceedings of the 12th International Symposium on Viral Hepatitis and Liver Disease, 2006. Conference Program and Book of Abstracts, Paris, France (2006)
25. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 245 (1997) 154-160
26. Rossi L., Leveri M., Marinelli D., Belli L., Civardi E., and Silini E.M. A heteroduplex mobility analysis assay based on capillary electrophoresis for the study of HCV quasispecies. J. Virol. Methods 110 (2003) 37-49
27. Sakamoto M., Akahane Y., Tsuda F., Tanaka T., Woodfield D.G., and Okamoto H. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J. Gen. Virol. 75 (1994) 1761-1768
28. Schuitemaker H., and Kootstra N.A. Isolation, propagation, and titration of human immunodeficiency virus type 1 from peripheral blood of infected individuals. Methods Mol. Biol. 304 (2005) 17-24
29. Simmonds P., Zhang L.Q., Watson H.G., Rebus S., Ferguson E.D., Balfe P., Leadbetter G.H., Yap P.L., Peutherer J.F., and Ludlam C.A. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 336 (1990) 1469-1472
30. Smith D.B., Pathirana S., Davidson F., Lawlor E., Power J., Yap P.L., and Simmonds P. The origin of hepatitis C virus genotypes. J. Gen. Virol. 78 (1997) 321-328
31. Stead J.D., and Jeffreys A.J. Allele diversity and germline mutation at the insulin minisatellite. Hum. Mol. Genet. 9 (2000) 713-723
32. Stein C.A., Levantis P., and Oxford J.S. Sequence analysis of proviral HIV RT amplified directly by a semi-quantitative technique from AZT treated patients. J. Med. Virol. 44 (1994) 115-121
33. Tamura K., Nei M., and Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. U S A. 101 (2004) 11030-11035
34. Vizmanos J.L., Gonzalez-Navarro C.J., Novo F.J., Civeira M.P., Prieto J., Gullon A., and Garcia-Delgado M. Degree and distribution of variability in the 5′ untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). J. Viral Hepat. 5 (1998) 227-240
35. Vogelstein B., and Kinzler K.W. Digital PCR. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 9236-9241
36. Wagner A., Blackstone N., and Cartwright P. Surveys of gene families using polymerase chain reactions: PCR sequences and PCR drift. Syst. Biol. 43 (1994) 250-261
37. Wilson J.J., Polyak S.J., Day T.D., and Gretch D.R. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J. Gen. Virol. 76 (1995) 1763-1771
38. Xia G., Gao F., Chai F., Nainan O.V., Alter M.J., and Margolis H.S. Genetic relatedness between hepatitis c virus variants: lessons from a general population survey. Proceedings of the 13th International Meeting on Hepatitis C Virus & Related Viruses, 2006. Conference Program & Book of Abstracts, Cairns, Australia (2006) 64
39. Yauk C.L., Bois P.R., and Jeffreys A.J. High-resolution sperm typing of meiotic recombination in the mouse MHC Ebeta gene. EMBO J. 22 (2003) 1389-1397
40. Zampino R., Marrone A., Mangoni E.D., Santarpia L., Sica A., Tripodi M.F., Utili R., Ruggiero G., and Adinolfi L.E. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment. J. Med. Virol. 73 (2004) 33-37